- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Stage IB-IIA-IIIA Non-Small Cell Lung Cancer; EGFRm ; Ex19Del; L858R; AZD9291; Phase III, adjuvant c
Total 494390 results
-
AstraZenecaActive, not recruitingStage IB-IIIA Non-small Cell Lung CarcinomaUnited States, Italy, Netherlands, Belgium, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Brazil, Hungary, Japan, Russian Federation, Turkey, China, Korea, Republic of, Germany, Hong Kong, Spain, Australia, Israel, Ukraine, Swed...
-
Shaare Zedek Medical CenterAstraZenecaRecruiting
-
AstraZenecaActive, not recruitingAdvanced Non Small Cell Lung CancerCanada, Poland, Taiwan, United States, Korea, Republic of, Japan, Russian Federation, Ukraine
-
European Organisation for Research and Treatment...AstraZenecaActive, not recruitingNSCLCFrance, Spain, Slovenia, Jordan, Poland
-
Soroka University Medical CenterActive, not recruiting
-
AstraZenecaParexelActive, not recruitingLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung CancerBelgium, United States, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Italy, Korea, Republic of, Brazil, Japan, Turkey, China, Malaysia, Germany, Spain, Australia, Hungary, Portugal, Switzerland, Israel, Philippines, Russian... and more
-
AstraZenecaRecruitingNon-Small Cell Lung CancerUnited States, Spain, China, Italy, Turkey, Argentina, United Kingdom, Canada, Germany, Brazil, Vietnam, Thailand, Poland, Russian Federation, Japan, Korea, Republic of, Taiwan, Malaysia, Singapore, Romania
-
AstraZenecaNo longer available
-
AstraZenecaCompletedNon-small Cell Lung CancerSweden
-
AstraZenecaCompletedCarcinoma, Non-Small-Cell Lung With EGFR Mutation PositiveChina
-
AstraZenecaRecruitingStage II-IIIB Non-small Cell Lung CarcinomaSpain, Korea, Republic of, Philippines, Italy, United States, Malaysia, Taiwan, Thailand, Hong Kong, United Kingdom, Singapore
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerUnited States, France, Germany, Korea, Republic of, Taiwan, United Kingdom, Spain, Italy, Japan, Australia
-
AstraZenecaParexelWithdrawnNon Small Cell Lung CancerItaly, Russian Federation, Spain, China, Netherlands, United States, Taiwan, France, Germany
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerFrance, Korea, Republic of, United Kingdom, Spain
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR T790M+ NSCLCCanada, Korea, Republic of, Taiwan
-
Hellenic Oncology Research GroupUnknownNon Small Cell Lung CancerGreece
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerKorea, Republic of, China, Australia
-
Tianjin Medical University Cancer Institute and...Recruiting
-
AstraZenecaCompletedNon Small Cell Lung CancerKorea, Republic of, Taiwan, United Kingdom, Spain, United States, Netherlands
-
AstraZenecaActive, not recruitingNon Small Cell Lung CancerBelgium, Korea, Republic of, Spain, United States, France
-
AstraZenecaCompletedNon Small Cell Lung CancerSpain, United Kingdom, France, United States
-
National University Hospital, SingaporeAstraZeneca; Singapore Clinical Research InstituteUnknownCarcinoma, Non-Small-Cell LungTaiwan, Hong Kong, Thailand, Singapore, Korea, Republic of
-
AstraZenecaParexelTerminatedNon Small Cell Lung CancerUnited States, Korea, Republic of
-
AstraZenecaParexelActive, not recruitingNon-small Cell Lung CancerItaly, Spain, United States, China, Germany, Israel
-
Dana-Farber Cancer InstituteNational Comprehensive Cancer NetworkActive, not recruitingNon-small Cell Lung CancerUnited States
-
AstraZenecaCompleted
-
AstraZenecaCompletedNon Small Cell Lung CancerItaly, United States, Canada, Korea, Republic of, Japan, Taiwan, Hong Kong, Spain
-
Ascentage Pharma Group Inc.Suzhou Yasheng Pharmaceutical Co., Ltd.RecruitingEGFR Positive Non-small Cell Lung CancerChina
-
AstraZenecaCompletedHealthy VolunteerUnited States
-
AstraZenecaDaiichi SankyoNot yet recruitingNon-small Cell Lung CancerChina, Taiwan, Korea, Republic of, Australia
-
Samsung Medical CenterActive, not recruitingNon-Small Cell Lung Cancer With EGFR T790M Mutation | With Brain and/or Leptomeningeal Metastasis | Failed Tyrosine Kinase InhibitorsKorea, Republic of
-
Oslo University HospitalAstraZenecaActive, not recruitingLung Cancer | Targeted TherapySweden, Finland, Denmark, Lithuania, Norway
-
AstraZenecaParexelCompletedEGFR Mutation Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerSpain, United States, Italy, Korea, Republic of, Malaysia
-
AstraZenecaRecruitingNon-Small Cell Lung CancerChina, United States, Chile, Vietnam, Thailand, Brazil, Bulgaria, Canada, Germany, India, Japan, Korea, Republic of, Poland, Russian Federation, Singapore, Turkey, Austria, Israel, Spain, Taiwan, Mexico, France, Italy, Peru, Switzerland, United...
-
MedSIRAstraZenecaCompletedNon-Small Cell Lung CancerSpain
-
AstraZenecaQuintiles, Inc.CompletedNon Small Cell Lung CancerKorea, Republic of, Spain, France
-
AstraZenecaCompletedEGFR Mutation Positive Advanced Non Small Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Australia
-
Dana-Farber Cancer InstituteAstraZenecaRecruiting
-
AstraZenecaCompletedNon Small Cell Lung CancerTaiwan
-
Shandong Cancer Hospital and InstituteAstraZenecaUnknownNonsmall Cell Lung Cancer | Brain Metastases | EGFR-TKI Resistant Mutation | AZD9291
-
Sun Yat-sen UniversityRecruitingNon-Small Cell Lung CancerChina
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerBelgium, United States, Korea, Republic of, Taiwan, United Kingdom, Netherlands
-
AstraZenecaParexelCompletedLung CancerCanada, Denmark, Italy, Spain, Belgium, Korea, Republic of, Brazil, China, Taiwan, Australia, Austria, United Kingdom, Sweden, Argentina, Saudi Arabia, Ireland
-
AstraZenecaActive, not recruitingAnticancer TreatmentUnited States, France, Germany, Spain, Sweden, United Kingdom, Canada, Italy, Korea, Republic of, Hungary, Japan, Russian Federation, China, Taiwan, Hong Kong, Netherlands, Australia, Mexico
-
University of Texas Southwestern Medical CenterAstraZenecaActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States
-
Chul KimBristol-Myers Squibb; AstraZeneca; Walter Reed National Military Medical Center; Hackensack Meridian HealthActive, not recruitingNonsmall Cell Lung Cancer | EGFR Gene MutationUnited States
-
Beijing Cancer Prevention & Treatment SocietyCancer Institute and Hospital, Chinese Academy of Medical SciencesRecruitingNon Small Cell Lung CancerChina
-
AstraZenecaQuintiles, Inc.CompletedLocally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV)United States
-
AstraZenecaTerminated